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The aim of this study was to test the hypothesis that 
intraaortic balloon pumping (IABP), by augmentation of 
coronary perfusion, might prevent reocclusion after 
emergency PTCA for acute myocardial infarction (AMI) 
and, by left ventricular unloading9 might improve left 
ventricular function. 114 patients with anterior AMI in 
whom reperfusion was achieved with emergency PICA were 
studied. After successful PTCA, 48 patients were treated 
with IABP for 2528 hours (group A) and 66 patients were 
treated with conventional therapy (group B). 
Predischarge angiography was performed at 2126 days. 
Left ventricular ejection fraction (LVEF) was assessed 
bY serial contrast ventriculograms. 
Results. ‘r!-x:e was no difference in baseline clinical 
and angiographic variables in the two groups. The 
incidence of reocclusion was significantly lower in 
group A (2.1% vs 16.9%, prO.04). An increase in LVEF in 
group A compared to group B attained marginal 
significance (9.2*13.0X vs 4.5+112.2%, ~~0.08). There 
were two vascular complications but no deaths from IABP. 
Conclusicn: These results suggest that PABP following 
emergency PICA for AMP prevents reocclusion and may add 
strength to reperfusion in the improvement of left 
ventricular function. 
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THE INSIGh.FICANCE OF HYPERTENSION AS A RISK 
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Previous reports of coronary arteriographic 
findings in Blacks have highlighted the paradox 
of a marked prevalence of hypertension (HTN) and 
other risk factors with a low rate of coronary 
artery disease (CAD) detection. These reports 
contain small numbers of Black Fts. The present 
study reports our experience in 1,455 Black Pts, 
and is the largest report to date from a single 
laboratory. Ages ranged from 22 to 87 yrs (mean 
58) with almost equal numbers of men and women. 
Significant CAD (stenosLs2 5061 in at least 
one vessel was present in only 47.6% of Pts. 
rag-stic regression analyses revealed that age, 
diabetes mellitus,lipid abnormalities,previous 
MI, and typical angina pectoris were the 
strongest predictors (pc.05) of CAD in men. 
Findings were similar il l women and also lnclud- 
ed smoking history. Atypical pain had a strong- 
ly negative predictive value in both sexes 
(M,p=.0264,w,p=.0030). HTN falled to achieve 
significant predictive value in either sex. 
We conclude that age, pain symptomsland risk 
factors other than HTN are the significant 
predictors for CAD in most angiographic 
series. These findings invite a reinterpreta- 
tion of past reports which have been shaped by 
ethnic comparisons. 
